» Articles » PMID: 36990513

SARS-CoV-2 Spike Variants Differ in Their Allosteric Responses to Linoleic Acid

Overview
Journal J Mol Cell Biol
Specialty Molecular Biology
Date 2023 Mar 29
PMID 36990513
Authors
Affiliations
Soon will be listed here.
Abstract

The SARS-CoV-2 spike protein contains a functionally important fatty acid (FA) binding site, which is also found in some other coronaviruses, e.g. SARS-CoV and MERS-CoV. The occupancy of the FA site by linoleic acid (LA) reduces infectivity by 'locking' the spike in a less infectious conformation. Here, we use dynamical-nonequilibrium molecular dynamics (D-NEMD) simulations to compare the allosteric responses of spike variants to LA removal. D-NEMD simulations show that the FA site is coupled to other functional regions of the protein, e.g. the receptor-binding motif (RBM), N-terminal domain (NTD), furin cleavage site, and regions surrounding the fusion peptide. D-NEMD simulations also identify the allosteric networks connecting the FA site to these functional regions. The comparison between the wild-type spike and four variants (Alpha, Delta, Delta plus, and Omicron BA.1) shows that the variants differ significantly in their responses to LA removal. The allosteric connections to the FA site on Alpha are generally similar to those on the wild-type protein, with the exception of the RBM and the S71-R78 region, which show a weaker link to the FA site. In contrast, Omicron is the most different variant, exhibiting significant differences in the RBM, NTD, V622-L629, and furin cleavage site. These differences in the allosteric modulation may be of functional relevance, potentially affecting transmissibility and virulence. Experimental comparison of the effects of LA on SARS-CoV-2 variants, including emerging variants, is warranted.

Citing Articles

Signal Propagation in the ATPase Domain of DNA Gyrase from Dynamical-Nonequilibrium Molecular Dynamics Simulations.

Kamsri B, Kamsri P, Punkvang A, Chimprasit A, Saparpakorn P, Hannongbua S Biochemistry. 2024; 63(11):1493-1504.

PMID: 38742407 PMC: 11154950. DOI: 10.1021/acs.biochem.4c00161.


Mechanistic insights into ligand dissociation from the SARS-CoV-2 spike glycoprotein.

Hasse T, Mantei E, Shahoei R, Pawnikar S, Wang J, Miao Y PLoS Comput Biol. 2024; 20(3):e1011955.

PMID: 38452125 PMC: 10959368. DOI: 10.1371/journal.pcbi.1011955.


Dynamical Nonequilibrium Molecular Dynamics Simulations Identify Allosteric Sites and Positions Associated with Drug Resistance in the SARS-CoV-2 Main Protease.

Chan H, Oliveira A, Schofield C, Mulholland A, Duarte F JACS Au. 2023; 3(6):1767-1774.

PMID: 37384148 PMC: 10262681. DOI: 10.1021/jacsau.3c00185.

References
1.
Davidson A, Kavanagh Williamson M, Lewis S, Shoemark D, Carroll M, Heesom K . Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein. Genome Med. 2020; 12(1):68. PMC: 7386171. DOI: 10.1186/s13073-020-00763-0. View

2.
Chi X, Yan R, Zhang J, Zhang G, Zhang Y, Hao M . A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Science. 2020; 369(6504):650-655. PMC: 7319273. DOI: 10.1126/science.abc6952. View

3.
Korber B, Fischer W, Gnanakaran S, Yoon H, Theiler J, Abfalterer W . Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. Cell. 2020; 182(4):812-827.e19. PMC: 7332439. DOI: 10.1016/j.cell.2020.06.043. View

4.
Behloul N, Baha S, Shi R, Meng J . Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein. Virus Res. 2020; 286:198058. PMC: 7282740. DOI: 10.1016/j.virusres.2020.198058. View

5.
Rogers T, Zhao F, Huang D, Beutler N, Burns A, He W . Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science. 2020; 369(6506):956-963. PMC: 7299280. DOI: 10.1126/science.abc7520. View